Human thoracic aneurysm of the ascending aorta (TAA) is a chronic disease characterized by dilatation of the aortic wall, which can progress to vessel dissection and rupture. TAA has several aetiologies, but all forms present common features, including tissue remodelling. Here, we determined and characterized the angiogenic process associated with TAA and its relation with wall remodelling.
Introduction
Thoracic aneurysm of the ascending aorta (TAA) is a chronic and multifactorial disease in which important remodelling of the arterial wall takes place. Several aetiologies of TAA have been characterized: monogenic forms with mutations in different gene, FBN1, TGFBR1/2, SMAD3, MYH11, and a-SMA, forms associated with a bicuspid aortic valve (BAV) and the degenerative form associated with aging. 1 TAA of these different aetiologies present common features, among which are elastic fibre and extracellular matrix (ECM) degradation occurring by elastolysis and collagenolysis in the medial layer. Moreover, areas of cystic medial degeneration are present in TAA wall characterized by smooth muscle cell (SMC) apoptosis, particularly around microvessels, and accumulation of mucoid substance. These areas, enriched in glycosaminoglycans, show structural disorganization and characterize pathological tissue remodelling in TAA. Recent work has shown that aneurysmal SMCs are epigenetically reprogrammed to constitutively increase Smad2 expression and phosphorylation with the consequence of stimulating a protective effect by the overexpression of anti-proteases in the medial layer. 2 -4 Surprisingly, while angiogenesis is a well-described feature leading to lesion progression in atheromatous arteries and abdominal aortic aneurysm, there is no reported evidence that such a process takes place in TAA. However, if one considers some of the TAA characteristics cited above, the possibility that angiogenesis occurs in TAA becomes highly plausible. In fact, both the mechanical properties and protein composition of the ECM have been shown to regulate the angiogenic properties of mesenchymal cells. 5, 6 Therefore, modifications of these two parameters through degradation of the ECM could modify the production of angiogenic factors by SMCs in TAA. This hypothesis is further supported by a recent publication, showing that a fibrillin mutation and the consequent elastin fragmentation in hypercholesterolaemic apoE 2/2 mice significantly enhanced intraplaque neovascularization. 7 Furthermore, we have shown recently that angiogenesis in human atheromatous disease is associated with substantial changes in the phenotype of medial SMCs. Indeed, SMCs underlying intimal lesions displayed an increased production of vascular endothelial growth factor-A (VEGF-A) conferring pro-angiogenic properties to them that persisted long after removal of the initial trigger of this phenotypic change, the atheroma-derived agonists of peroxisome proliferator-activated receptor-g. One could thus hypothesize that TAA-associated reprogramming of SMCs could, in a similar manner, support an angiogenic response. For these reasons, the aim of this study was to investigate whether neo-angiogenesis occurs in TAA. Our results show that TAA displays an increased density of structurally fragile vessels in the media in association with an imbalance in angiogenic factor levels. Our data further suggest that neovessels in the aneurysmal medial layer could participate in aortic wall remodelling by reinforcing the accumulation of bloodborne proteases in the vessel wall.
Methods

Patients and aortic specimens
The clinical research protocol was approved by the local Ethics Committee (CPP 05 04 32, Ambroise Paré, Boulogne, France, April 2005; updated in March 2008) and was in accordance with the principle of the Declaration of Helsinki. 8 All patients gave informed consent. Aneurysmal ascending aortic specimens were collected during aortic surgery (Hô pital Bichat). Ninety specimens were divided into three groups according to their clinical features and genetic background: Marfan (n ¼ 27, mean age: 39 + 13 years), TAA associated with BAVs (n ¼ 37, mean age: 55 + 15 years), and the degenerative form (n ¼ 26, mean age: 71 + 8 years). The clinical data associated with this series of patients are reported in Table 1 . All specimens were from aneurysms of .50 mm in diameter. Normal ascending aortas were obtained from organ transplant donors (n ¼ 50) with the authorization of the French Biomedicine Agency (PFS09-007) and in accordance with the Declaration of Helsinki. Aneurysmal tissues were sampled in the outer curvature, the most dilated part of the ascending aorta, and in the sinus of Valsalva for Marfan patients. A small piece of each aortic sample was fixed in paraformaldehyde (PFA) for histology. Aortic tissue preparation consisted of an immediate dissection of the aortic wall with the separation of the medial and adventitial layers at the junction of the external elastic lamina (EEL) and the adventitia.
Immunohistology of human aortas
The fixed sections were treated for antigen retrieval by heating with citrate buffer, pH 6. For fibroblast growth factor-acidic (FGF-a), plasminogen, and erythrocyte staining, endogenous peroxidase was quenched with 3% (v/v) hydrogen peroxide. Non-specific binding was blocked by incubation with 1% (v/v) normal foetal calf serum for 30 min at 378C. Slides were incubated for 1 h 30 min at 378C with the primary antibody: anti-vWF (5 mg/mL; DAKO), anti-TSP-1 (5 mg/mL; Abcam), anti-Ang-1 (10 mg/mL; R&D Systems), anti-Ang-2 (20 mg/mL; R&D Systems), anti-FGF-a (5 mg/mL; Santa Cruz), anti-albumin (1/1000 dilution; DAKO), anti-plasminogen (10 mg/mL; Abcam), anti-VE-cadherin (5 mg/mL; Bender Medsystems), anti-collagen IV (2 mg/mL; Abcam), anti-a-SMA (2 mg/mL; DAKO), or anti-a2b3-integrin (2 mg/mL; home made 9 ). Nuclei were stained with Hoechst stain and visualized in blue. Detection of FGF-a and plasminogen was performed with Histogreen (Histoprime Linaris), and slides were counterstained with nuclear red. For the details of histopathological evaluation, image acquisition, and transmission electron microscopy, see Supplementary material online.
Whole-mount staining
Aortic specimens were fixed in 4% PFA overnight. Free aldehyde groups were quenched with glycine at 100 mM pH 7, and the aortic tissue was permeabilized in Triton 2% in DMSO 20% containing 2% foetal calf serum. The antibody to MYH11 (10 mg/mL; Millipore) and lectin UEA rhodamine (5 mg/ mL; VectorLab) were incubated simultaneously followed by incubation with the secondary antibody (Alexa Fluor 488). Tissue samples were then dehydrated in Tetrahydrofuran (Sigma-Aldrich) baths at 25, 50, 75, and 100%, cleared in 1 vol benzyl alcohol with 2 vol benzyl benzoate (Sigma-Aldrich), and examined by fluorescence microscopy in a glass petri dish, without mounting.
Aortic tissue samples
Aortic tissue extractions (protein, mRNA) were performed directly from frozen aortic media stored at 2808C. The aortic samples were first cryogenically pulverized in liquid nitrogen, using a freezer mill (6870 Spex SamplePrep). Between 30 and 150 mg of crushed aortic powder was used for each extraction.
Small pieces of aortic media were incubated for 24 h in RPMI culture medium containing 1% L-glutamine and 1% penicillin, streptomycin, and amphotericin at 378C (5% CO 2 ) to study extracellularly secreted or released proteins (tissue-conditioned medium). The volume of culture medium was adjusted to the sample wet weight (6 mL/g). Each tissue-conditioned medium was collected and centrifuged (3000 g, 15 min, at 208C).
For the details of protein extraction, proteomic array, ELISA, immunoblotting, RT-qPCR, cell culture, and cell migration assay, see Supplementary material online.
Cell permeability measured by the xCELLigence system
The xCELLigence system (Roche Applied Science) has three components: an analyzer, a device station, and a 16-well E-plate. The dimensionless parameter cell index (CI) was used to quantify cell status based on the measured cell -electrode impedance. 10 A CI is a quantitative measure of cell status in a well, including the cell number, cell viability, adhesion degree, and morphology. 'Normalized cell index' at a specific time point is acquired by dividing the CI value by the value at a reference time point.
Statistical analysis
Values are expressed as medians (dot plot graphics) or as means + SEM. The significance of differences between groups was tested using the KruskallWallis non-parametric test followed by Dunn's post hoc test, the paired t-test, the Mann-Whitney test, or a two-way analysis of variance followed by the Bonferroni post hoc test, when appropriate. Correlations were evaluated using the Spearman test. A value of P ≤ 0.05 was considered significant and *P , 0.05, **P , 0.01, ***P , 0.001.
Results
Blood vessels are located in the media of TAA
During the separation of human TAA media from adventitia, we observed that blood-red areas were present on the external medial surface of the curvature, suggesting possible angiogenic vessels penetrating into the media ( Figure 1A) . Such areas were not seen in healthy aortas.
To address the possible angiogenic nature of these areas, immunostaining for von Willebrand Factor (vWF), a marker of blood vessels, was performed on transverse sections of TAA and healthy aortas. The results showed numerous blood vessels inwardly penetrating into the external media of TAA ( Figure 1B-D) . The quantification of vWF-positive blood vessels showed that they were increased in TAA walls compared with those of undilated healthy aortas (P , 0.001; Figure 1C ). The neovessel density was significantly different in Marfan and degenerative groups compared with healthy aortas (P , 0.001 and ,0.01, respectively), in contrast to BAV. Microvessel density was evaluated according to their location in the medial layer, which was subdivided into four parts. The first corresponds to the area very close to the EEL, at the border between the medial and adventitial layers. The rest of the medial layer was then separated into three equal parts: the external 1/3 closest to the adventitia, the middle section, and the inner 1/3, closest to the intima. The results showed that blood vessel density was significantly increased in TAAs compared with healthy aortas (P , 0.0001) and in the external part compared with the internal part of the aortic media (P , 0.0001; see Supplementary material online, Table S2A ).
In healthy aortas, blood vessels were mainly located close to the adventitia and consisted of typical vasa vasorum (see Supplementary material online, Table S2B ). In TAA, neovessels were increased close to the adventitia but many extended inwardly across the external 1/3, reaching the middle part of the medial layer with a significantly different distribution between the external 1/3 and the internal 1/3 of the TAA media, particularly in Marfan (P , 0.05) and degenerative groups (P , 0.01), whereas BAV-associated TAA was not significantly different from healthy aortas (see Supplementary material online, Table S2C -E). Nevertheless, these neovessels never reached the intima. Whole-mount immunostaining was performed with a lectin specific for endothelial cells, and the TAA tissue was cleared to permit visualization across the whole aortic wall from the adventitia to the intima. The results confirmed that the blood vessels originate from the adventitia and penetrate into the media ( Figure 1E ). Thus, the number of blood vessels was increased in TAA media with a negative gradient from the adventitia to the mid-media. Taken together, these results showed that an angiogenic process occurs in TAA, and that neovessels penetrating the media likely derive from adventitial vessels. To evaluate the relationship between neovessel density and the progression of dilatation, a correlation was established between the maximal diameter of the TAA and the number of vessels per mm 2 of tissue. (r 2 ¼ 0.23, P , 0.03; see Supplementary material online, Figure S1 ).
Differential protein expression of angiogenic factors in TAA compared with healthy aortas: identification and localization
To study the equilibrium between angiogenic factors, the protein levels of 55 factors were measured from pooled aortic extracts of either media or adventitia and from pooled samples of culture medium conditioned by incubation with media or adventitia from TAA and healthy aortas Medical treatment
Unknown, n 8
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The cohort of patients studied presented two groups: patients with healthy aortas and those with aneurysmal thoracic ascending aortas of three potential aetiologies: Marfan syndrome, BAV, and the degenerative form. Every aneurysm had an aortic diameter above 50 mm. Results are expressed as means + SD. BAV, bicuspid aortic valve; TAA, thoracic aneurysm of the ascending aorta; ARA2, angiotensin II receptor antagonist; ACEI, angiotensin-converting enzyme inhibitor; FBN1, fibronectin 1; TGFBR1/2, transforming growth factor receptor 1/2.
(the screening of angiogenic factors is shown in Supplementary material online, Figure S2 ). Four types of samples were thus defined: the medial extract (1), the adventitial extract (2), the medial conditioned medium (3), and the adventitial conditioned medium (4). Among these 55 factors, we found that 34 were dysregulated in TAA compared with healthy aortas. Expression of some of these proteins was found in only one compartment and was not detectable in the other compartments, e.g. angiopoietins 1 and 2 (Ang-1 and -2), latency-associated protein (LAP), persephin, and thrombospondin-2 (TSP-2) were found only in the TAA medial extract, and dipeptidyl peptidase IV (DPPIV) was present only in the TAA adventitial extract. Also, urokinase-type plasminogen activator (u-PA) was found only in the TAA adventitial conditioned medium. A differential relative expression factor for each compartment was determined, defined as the ratio between TAA values and values of healthy aorta for each factor in the extract and the conditioned medium. Factors can be classified into four groups as illustrated in Figure 2A : Group I contains factors that were greatly increased in TAA compared with healthy aortas (beyond 10 500) (in red), Group II comprises factors that were more moderately increased (between 2 and 10 500) (in orange and yellow), and Group III comprises factors that were decreased in TAA compared with healthy aortas (,0.9; in green). This group includes factors with a role in angiogenesis (e.g. endoglin) but also factors with an anti-protease role, such as the tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-4. A fourth group included factors with a ratio not significantly different between TAA and healthy aortas (ratio between 0.9 and 1.9; in grey; Figure 2A) .
Results can be analysed by comparing the compartmental ratio (value in TAA/value in healthy aorta) two by two for Groups I (mostly red) and II (mostly orange and yellow; Figure 2A ). Comparing medial and adventitial extracts reveals that plasminogen, Ang-1, Ang-2, TSP-1, platelet-derived endothelial cell growth factor (PD-ECGF), insulin-like growth factor-binding protein-1 (IGFBP-1), endocrine gland-derived vascular growth factor (EG-VEGF), LAP, TSP-2, persephin, matrix metalloproteinase-9 (MMP-9), and pentraxin-3 were all more abundant in TAA media. Results are expressed by the ratio of the pixel density measured in TAA to that measured in healthy aortas. The pixel density was measured in the media and the adventitia in tissue extracts and in conditioned medium (C.M.). The scale bar represents a colour code corresponding to the ratio values. (B -F) Protein content per gram tissue measured in medial and adventitial layers from healthy, Marfan, BAV, and degenerative aortas (n ¼ 18, 11, 10, and 13 for media and n ¼ 9, 9, 10, and 9 for adventitia, respectively). Non-parametric Kruskall -Wallis tests were performed (P , 0.01 for all angiogenic factors, except for VEGF-A: NS) followed by Dunn's post hoc tests (*P , 0.05, **P , 0.01, ***P , 0.001).
Angiogenesis in TAA
Comparing the medial extract with the medial conditioned medium reveals which factors are over-released by the TAA media. The following diffusible factors were increased in TAA: plasminogen, interleukin-8 (IL-8), FGF-a, and monocyte chemoattractant protein-1 (MCP-1).
In the adventitial layer, IL-8 and DPPIV were found in the extract but not in the corresponding conditioned medium in contrast to plasminogen, u-PA, FGF-a, MCP-1, and placental growth factor (PlGF), which were found in both adventitial tissue extracts and conditioned medium, indicating that they are diffusible factors (Figure 2A) .
The analysis of medial and adventitial conditioned medium reveals an increased diffusion of plasminogen, FGF-a, and MCP-1 from samples of both TAA layers. Interestingly, MMP-8 secretion was decreased in both TAA layers compared with those of healthy aortas (Figure 2A) .
To confirm the semi-quantitative differential expression from a pool of patients, quantitative studies using ELISA were performed on individual proteins selected from the data in Figure 2A . Results showed that protein levels of VEGF-A and PlGF were similar in TAA and healthy aortas, both in the media and in the adventitia (except for PlGF which increased in degenerative tissue; Figure 2B ; see Supplementary material online, Figure S3 shows PlGF content in aortas). Moreover, the transcriptional expression study in medial extracts showed a similar level of VEGF-A, PlGF, and platelet-derived growth factors (PDGF-A and PDGF-B) in TAA and healthy aortas, thus strengthening the proteomic array results ( Figure 3A ; quantification of PlGF and PDGF-A and -B mRNA in media is shown in Supplementary material online, Figure S4 ).
Among the angiogenic factors, which were differentially expressed in TAA, we chose to study further Ang-1, Ang-2, TSP-1, and FGF-a as candidates for the angiogenic switch. Their protein levels were quantified by ELISA in individual aortic extracts and in conditioned medium. Results showed an increase for all four factors in TAA compared with healthy aortas in the both medial and adventitial tissue extracts ( Figure 2C -F ) . However, Ang-1, FGF-a, and TSP-1 levels were mostly similar in the conditioned medium of TAA and healthy aortas (see Supplementary material online, Table S3) .
At the transcriptional level, further analysis demonstrated that TSP-1 and FGF-a mRNA expression was similar in aneurysmal and healthy medial samples ( Figure 3D and E) . But interestingly, the expression of angiopoietins was increased in TAA medial tissue compared with healthy media, particularly angiopoietin-1 ( Figure 3B and C ) . However, their transcriptional expression profile was similar in the adventitia in all four groups (as well as FGF-a and TSP-1; data not shown). Additionally, the expression of angiopoietins was also studied in SMCs cultured in vitro, but their overexpression observed in TAA tissue was no longer observed (data not shown).
Histological studies were performed on aortic serial sections to determine tissue structure, vessel localization, and angiogenic factor presence and distribution in the media. Staining with Masson's trichrome showed the presence of tissue remodelling in TAA media with elastic lamellar disorganization (Figure 4) . On the contrary, healthy media had parallel and continuous elastic lamellae. Immunostaining for vWF, specific for endothelial cells, demonstrated that neovessels were mostly located in the mucoid areas in TAA. The angiogenic factors TSP-1, Ang-1, Ang-2, and FGF-a were increased in TAA, particularly in the ECM. It is interesting to note that Ang-1 and Ang-2 accumulated in the neovessel endothelial cells.
In summary, Ang-1, Ang-2, FGF-a, and TSP-1 were increased in TAA media, particularly in the ECM, and more specifically in the areas of mucoid degeneration and neovessel endothelial cells.
Hypoxia and contractile SMC phenotype in TAA
Hypoxia was studied in TAA as a potential stimulus of angiogenesis in TAA. The hypoxia markers, hypoxia-inducible factor-1 alpha (HIF-1a) and sirtuine-1 (Sirt-1), were analysed by western blotting from tissue extracts. No difference was revealed between healthy and aneurysmal aortas (data not shown).
Since SMC dedifferentiation into myofibroblasts is able to promote angiogenesis, 11, 12 SMC phenotype was investigated in TAA. We thus performed immunostaining and western blotting on aortic tissues for MYH11 and its isoforms, SM1 and SM2. MYH11 levels were identical in TAA and healthy aortas whatever the isoform studied (data not shown). These results indicate that SMCs in TAA maintain their contractile phenotype and do not show signs of marked dedifferentiation into myofibroblasts. In summary, the modified expression of angiogenic factors in TAA appears to occur without the involvement of hypoxia or a change of SMC phenotype.
Neovessels have abnormal morphology in TAA
The paradoxical increase in both pro-and anti-angiogenic factors in TAA media might induce abnormal angiogenesis. We thus investigated the possibility of an incomplete structure of neovessels by performing co-immunostaining for vWF and different vessel structural components. Neovessels found in TAA media were compared with adventitial vessels (in both TAA and healthy aortas) as controls ( Figure 5 ). The mature, structurally complete vessels in the adventitia were composed of endothelial cells lying on a basal lamina composed of collagen IV and connected to each other via adherent junctions, which stained for VE-cadherin. In addition, a-actin-positive cells (SMCs/pericytes) surrounded the vessels forming one or several layer(s) ( Figure 5A , B, and H ). In contrast, co-immunostaining in TAA media showed that neovessels can lack mural cells ( Figure 5C , D, and H ) and adherent junctions ( Figure 5D , E, and H ), and may also have a discontinuous or absent basal lamina (Figure 5C , D, G, and H ). Some erythrocytes visualized by phase contrast microscopy were located outside the medial neovessels ( Figure 5C, D, and I ).
An ultrastructural study of neovessels demonstrated pericytes with many cytoplasmic vesicles surrounding endothelial cells containing vacuoles ( Figure 5F ). The basal lamina displayed discontinuities and the lumen was encroached upon by endothelial cell bulging ( Figure 5F and G).
To assess vessel permeability to circulating cells, immunostaining for platelets with a specific antibody against a2b3-integrin was performed. We observed platelet aggregates exclusively in the adventitia and inside blood vessels in all four groups (data not shown). However, immunostaining for plasma proteins, i.e. albumin and also the protease precursor, plasminogen, was observed in the TAA media but not in that of healthy aorta ( Figure 6 ). These data indicate that neovessels are permeable to plasma proteins, thus leading to their accumulation in the TAA media. We further investigated protease accumulation in media extracts and quantified protein levels of MMP-3, -7, -9, and -19, known to be involved in tissue remodelling ( Figure 6E-H ) . MMP-9 and -19 proteins were increased in TAA media extracts compared with healthy aortas, although their expression by medial cells was similar ( Figure 6G and H, and see Supplementary material online, Figure S5C and D). Medial cells expressed MMP-2, -3 (at very low level), -9, and -19 mRNA similarly in healthy and aneurysmal medial cells as shown in Supplementary material online, Figure S5 . However, MMP-7 and -12 (specific of macrophage expression) were not expressed by medial cells (data not shown).
The effect of secreted and diffusible angiogenic factors on an endothelial cell monolayer was evaluated. Impedance measurements reflecting permeability were performed in vitro in the presence of aortic layerconditioned medium. As a positive control, endothelial cells were incubated with thrombin, a serine protease, which is known to alter endothelial barrier function 13 ( Figure 7A and B) . Results showed that an endothelial cell monolayer incubated with conditioned medium (from either TAA or healthy aortas) had decreased impedance, demonstrating that endothelial cell permeability was increased. We explored further the capacity of migration and proliferation of endothelial cells in vitro in the presence of conditioned medium of healthy and aneurysmal aortas ( Figure 7C and D) . Results showed that endothelial cell incubation with healthy aorta-conditioned medium inhibited their migration/ proliferation compared with the unstimulated condition and also incubation with TAA-conditioned medium. Taken together, these results suggest that endothelial cell incubation with media-conditioned medium increases the cell permeability in all four groups, but only the TAAconditioned medium favours endothelial cell migration/proliferation.
Discussion
In this study, we have investigated and characterized angiogenesis in TAA. We demonstrated the presence of neovessels in the external two-thirds of the TAA media, likely originating from pre-existing adventitial vessels. They became scarcer approaching the intima and neovessels were totally absent in the inner third of the media. This aspect differs from observations in atheroma where neovessels can reach the intimal plaques and induce intraplaque haemorrhages.
14 One important point in this study is the fact that TAA angiogenesis occurs in the absence of modifications in VEGF-A levels. This contrasts with descriptions in atheromatous aortas where the angiogenic response was shown to be associated with a lipid-dependent stimulation of VEGF-A expression by SMCs. 15 Although VEGF-A is the most common mediator of angiogenesis, new VEGF-independent mechanisms have been identified associated with vascular diseases. 16 Similarly, VEGF-independent mechanisms have also been reported in some cancers. 17 Our study was non-exhaustive but clearly demonstrated a disequilibrium of pro-and anti-angiogenic factors in TAAs compared with healthy aortas. In particular, both Ang-1 and Ang-2 were overexpressed in aneurysmal medial tissue. It has been demonstrated that mice overexpressing Ang-1 in the skin produced larger, more numerous, and more highly branched blood vessels. 18 Ang-2 is involved in vascular remodelling, 19 and our results showed that Ang-2 mainly co-localized with the endothelial cells. Moreover, Ang-2, associated with VEGF-A, can induce an angiogenic response and an increase in vessel permeability. 20 Taken together, these data suggest that, together, Ang-1 and Ang-2 could promote angiogenesis and participate in tissue remodelling in TAA. In contrast to Smad2, which is epigenetically up-regulated in TAA, 3 the overexpression of angiopoietins was lost when SMCs were cultured in vitro, implicating a microenvironment-dependent transcriptional regulation.
It is noteworthy that some angiogenic factors were more greatly increased in the degenerative form of TAA compared with BAV and Figure 3 Ang-1 and -2 are overexpressed by cells in TAA media. Quantification of mRNA expression from medial layer cells normalized to b-actin expression in healthy aortas, Marfan, BAV, and degenerative TAA (n ¼ 9, 7, 10, and 4, respectively). Non-parametric Kruskall-Wallis tests were performed (P , 0.01 for Ang-1 and -2, and NS for VEGF-A, TSP-1, and FGF-a) followed by Dunn's post hoc tests (*P , 0.05, **P , 0.01, ***P , 0.001).
Angiogenesis in TAA Marfan forms, particularly for PlGF, Ang-1, Ang-2, and FGF-a. Thus, despite the fact that different forms of TAA present many common features, each aetiology can have its own particularity.
TSP-1, also increased in TAA media, is an adhesive glycoprotein which mediates cell-to-cell and cell-to-matrix interactions. 21 It acts as a powerful endogenous inhibitor of angiogenesis both indirectly, Figure 4 Angiogenic factors are increased in TAA media. Serial sections were used to localize different angiogenic factors in the same area of the wall in healthy Marfan, BAV, and degenerative aortas (n ≥ 5 in each group). Masson's Trichrome shows general tissue morphology with cytoplasm in pink, collagen in green, nuclei in black, and erythrocytes in red. Black stars indicate the mucoid areas. In the same area, microvessels are immunostained for vWF in red. TSP-1, Ang-1, and Ang-2 appear also in red in serial sections. Elastic lamellae are green due to their autofluorescence. FGF-a immunostaining appears in green with pink cytoplasm, red nuclei, and dark pink erythrocytes (nuclear red counterstaining). Scale bar ¼ 50 mm. Figure 5 Microvessels in TAA media have an incomplete structure. The structure of vessels in the adventitial layer of healthy aorta (n ¼ 5) and TAA (n ¼ 6) (A and B) was compared with that in the aneurysmal medial layer (n ¼ 6) (C-E). Vessel structure was characterized in serial sections by co-immunostaining with vWF (in red) and specific proteins involved in vessel formation (in green): VE-cadherin (adherent junctions between endothelial cells), collagen IV (basal lamina), and a-SMA (a-smooth muscle actin, which stains pericytes and smooth muscle cells). (H ) Quantification of medial vessels presenting co-immunostaining for vWF and neovessel ultrastructural components: a-SMA (51%), collagen IV (90%), or VE-cadherin (76%) in TAA. Medial microvessels were compared with adventitial vessels as control (100%, n ¼ 6 different patients). A non-parametric Kruskall-Wallis test was performed (P , 0.0001) followed by Dunn's post hoc test (*P , 0.05, **P , 0.01, ***P , 0.001). (I) Erythrocytes, detected using diaminobenzidine (DAB), were present outside the microvessels (inset).
by sequestering angiogenic growth factors and effectors in the ECM, and directly, by inducing an anti-angiogenic programme in endothelial cells. 11 Its increase and sequestration in TAA media could promote neovessel permeability and could favour the retention of angiogenic factors in the ECM. In this case, its role within the TAA media would be protective by trapping angiogenic factors and temporarily avoiding their release. Thus, despite the fact that the quantity of angiogenic factors was increased in TAA, their mRNA expression by medial cells was similar whatever the origin of the TAA, suggesting that angiogenic factors were retained within the tissue (e.g. FGF-a). This retention in the ECM, which also includes Ang-1and Ang-2, could be controlled by TSP-1. Angiogenesis requires destruction of the basement membrane and local degradation of the ECM to allow migration and proliferation of endothelial cells and the release of ECM-bound growth factors. Indeed, it has been recently demonstrated that the presence of a Marfanlike fibrillin mutation in atheroma-prone apoE 2/2 mice enhanced intraplaque neovascularization, elastic fibre fragmentation, and finally atherothrombotic complications in this experimental model. 7 In accord with these recent experimental observations, we observed an increased angiogenic tendency in human Marfan TAA compared with the other aetiologies. Nevertheless, comparing the different aetiologies requires further specific studies. Also, we show that the permeability of neovessels is associated with a lack of mural cells, low VE-cadherin levels suggesting decreased endothelial cell interactions, reduced collagen IV levels indicating anomalies of the basal lamina, and with many endothelial cytoplasmic vacuoles. Notably, endothelial permeability could be increased by the conditioned medium from healthy and also from aneurysmal aortas ( Figure 7A and B) . However, only TAA-conditioned medium was in favour of migration and proliferation of endothelial cells ( Figure 7C and D). These results suggest that while in healthy media the microenvironment inhibits the formation and growth of neovessels, this inhibition is lifted in TAA media, thus leading to the formation of incomplete and leaky neovessels. The hyperpermeability could participate in the increase in plasma proteins within the TAA wall. It is known that several proteases are increased in TAA: MMPs, but also proteases of the plasminergic system: t-PA and u-PA, which are produced by the SMCs. 4, 12, 22 Indeed, our results showed an increase in proteases:
plasminogen, MMP-9, and MMP-19 in TAA media as well as u-PA in TAA adventitia ( Figure 6G and H and see Supplementary material online, Figure S2 ). These proteases might increase neovessel permeability by weakening the neovessel ultrastructural components such as pericytes and adherent junctions, especially since tissue metalloproteinase inhibitors, TIMP-1 and TIMP-4, were decreased in TAA. Thus, the hyperpermeability of neovessels in TAA could be the result of several events: an imbalance of pro-/anti-angiogenic factors and of proteases/anti-proteases, and the presence of incomplete neovessels. The imbalance between deleterious proteases and protective antiproteases is clearly in favour of a degradation of the elastic lamellae and the formation of mucoid areas. Our previous work showed also that overexpression of the serine protease inhibitors, protease nexin-1 and plasminogen activator inhibitor-1, in TAA SMCs was protective, in favour of a progressive aneurysmal dilation, avoiding acute wall dissection. 4 We have observed that neovessels were mostly located in the mucoid degeneration areas, suggesting that ECM degradation facilitates neovessel invasion. We postulate that the imbalance of expression between proteases and TIMPs induces ECM degradation leading to the release and activation of factors promoting angiogenesis such as MMPs. Moreover, angiogenic factors mainly located in mucoid areas can increase the migration and proliferation of endothelial cells from the adventitia and promote angiogenesis, forming areas of weakness and important tissue remodelling.
The correlation study showed that the extent of angiogenesis appears to increase with the advancement of TAA dilatation. Thus, we hypothesize that angiogenesis in TAA may have a permissive and deleterious effect and could participate in the disease evolution.
Our data demonstrated that angiogenic activity was increased adjacent to the TAA adventitial layer. This is in accord with the results of Gomez and co-workers showing that the inactive form of TGF-b1 (LAP) was increased in TAA, in particular close to the adventitia, and co-localized with the degraded elastic lamellae. 23 Furthermore, we
showed that the angiogenesis-related factors, DDPIV and IL-8, are expressed exclusively in the TAA adventitial compartment. More investigations are required to confirm our semi-quantitative data and their biological implications in TAA angiogenesis and remodelling, but together our results suggest that the adventitial layer also plays an important role in the progression of dilatation. Finally, we have shown that the angiogenesis in TAA does not appear to be related to environmental hypoxia. On the contrary, it is probable that the depletion of SMCs and elastic fibres makes the aneurysmal media more permissive to the diffusion of O 2 and free radicals. A putative regulation pathway such as NF-kB may be implicated: the NF-kB transcription factors could alter gene expression involved in the angiogenic process in TAA as observed in solid tumours. 16 To support this postulate, the quantification of angiogenesis-related proteins revealed increased IL-8, MMP-9, and IGFBP, which can all be regulated by the NF-kB signalling pathway. 24 However, the precise molecular mechanism leading to the overexpression of angiopoietins in TAA media remains currently unclear.
In conclusion, our study has demonstrated for the first time that an angiogenic process takes place in the TAA media. Until now, the media were considered to be the principal wall layer involved in TAA pathogenicity. But we have demonstrated here that the adventitial layer may also play an important role in disease evolution by promoting the sprouting of neovessels towards the TAA media, highlighting the importance of interactions between each of the vascular compartments and the need to consider the whole tissue in context. Angiogenesis appears to be induced by an imbalance between pro-and anti-angiogenic factors, and the neovessels were shown to be leaky. Their permeability led to leakage of plasma proteins and promoted plasma zymogen accumulation in the aneurysmal wall. The tissue microenvironment is favourable to ECM degradation, formation of mucoid areas, and endothelial cell proliferation/migration. Neovessel invasion into the media, together with the presence of mucoid areas, plays an important role in tissue remodelling and probably participates in weakening the aortic wall by impairing its structural integrity and potentially promoting dissection. Finally, more investigations are necessary to identify the precise molecular mechanisms promoting this angiogenesis in TAA and the potential differences between aetiologies.
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